A protein S test measures how much working protein S is circulating in your plasma, and protein S is one of the natural brakes your body uses to stop a clot from spreading beyond the injury that triggered it. Because that brake is measured indirectly, a single number on a lab report can be misleading: pregnancy, a recent clot, hormonal contraception and even how the sample was frozen can all push the result down in someone with perfectly normal genes. In this article you will learn what the three different protein S assays actually measure, how to read the value printed on your report, which everyday situations produce a falsely low result, when this test genuinely changes medical care, and what recent research says about diagnosing protein S deficiency reliably.
What the protein S test measures
Blood clotting is a controlled demolition. When a vessel is injured, a cascade of clotting factors builds a fibrin plug within seconds. If nothing stopped that cascade, the plug would keep growing until it blocked the vessel entirely. Protein S is part of the shutdown system.
Protein S is made in the liver and in the cells that line your blood vessels, and it depends on vitamin K to be assembled correctly. Its main job is to act as a cofactor: it does not switch off clotting by itself, it makes activated protein C dramatically more efficient at chopping up two of the most powerful clotting factors, factor Va and factor VIIIa. Think of activated protein C as the technician and protein S as the tool that lets the technician work quickly. If you want the companion side of that partnership, read our protein C blood test guide.
There is a complication that explains most of the confusion around this test. Only about 40 percent of the protein S in your blood floats freely and can do this job. The rest is stuck to a carrier called C4b-binding protein, which is part of the immune system’s complement machinery. Bound protein S is present but unavailable. Anything that raises C4b-binding protein — inflammation, infection, pregnancy — mops up free protein S and lowers the useful fraction without any inherited defect being involved.
Protein S sits alongside the other natural anticoagulants your doctor may check at the same time, particularly antithrombin. Our antithrombin III test guide covers that partner marker, and the broader picture of how these results fit together appears in our coagulation panel results guide.
The three protein S tests, and why your lab chose one
When a report says “protein S,” it may mean one of three genuinely different measurements. They answer different questions and they fail in different ways, which is why laboratories often run more than one before committing to a diagnosis.
| Assay on your report | What it actually measures | What it is good for | Main limitation |
|---|---|---|---|
| Protein S activity (functional) | How well protein S speeds up activated protein C in a clotting reaction | Catching every type of deficiency, including proteins that are present but defective | Easily disturbed by factor V Leiden, lupus anticoagulant, anticoagulant drugs and sample handling |
| Free protein S antigen | The quantity of unbound protein S available to work | The most reliable everyday screen; far less prone to interference | Normal when the protein is present in the right amount but functionally faulty |
| Total protein S antigen | Free plus carrier-bound protein S added together | Sorting a confirmed deficiency into its subtype | Can look completely normal while the usable free fraction is low |
Why the subtype matters
Hematologists sort inherited protein S deficiency into three types. Type I means low total and low free protein S: the body simply makes too little. Type III means normal total but low free protein S: enough is made, but too much is tied up on its carrier. Type II, the rarest, means normal amounts of a protein that does not work properly, so only the activity assay detects it. Type I and type III are now understood to be different expressions of the same underlying genetic picture in many families, which is why a specialist may repeat testing in relatives rather than relying on one person’s numbers.
How to read your protein S report
Protein S is reported as a percentage of normal pooled plasma activity, not in milligrams. A value of 100 percent does not mean perfect health, it means you sit at the average of the reference population. Most adult laboratories place the lower limit somewhere between 60 and 70 percent, and healthy women typically run lower than healthy men across the whole range. Always compare your number with the reference interval printed on your own report, because assay platforms differ enough that borrowing a range from another lab is genuinely unsafe.
| Where your result falls | What it usually means | Typical next step |
|---|---|---|
| Within the lab reference interval | No evidence of protein S deficiency at the time of the draw | No repeat needed unless the clinical suspicion is high |
| Slightly below the interval | Most often a temporary or drug-related dip rather than an inherited defect | Repeat in a stable, unmedicated state, usually weeks to months later |
| Clearly low on activity but normal on free antigen | Often assay interference rather than true deficiency | Review medications and check for factor V Leiden or lupus anticoagulant |
| Persistently low on two separate occasions | Possible inherited deficiency, especially with a family history | Hematology referral, subtype testing and family discussion |
| Above the reference interval | No recognized disease; high protein S is not treated | No action required |
One practical point catches many people out. If your clotting screen was ordered at the same time, a prolonged prothrombin time can point toward the same vitamin K pathway that protein S depends on; our prothrombin time results guide and our INR explainer unpack those two numbers, and a related value appears in our partial thromboplastin time guide.
Why one low protein S result is rarely a diagnosis
This is the single most useful thing to understand about the test, and it is the reason hematologists ask for repeat samples so often. Protein S has the widest overlap between healthy people and truly deficient people of any of the natural anticoagulants, and its level moves with circumstances more than protein C or antithrombin do.
Run through this checklist before you treat a low number as a verdict. Each item on it can push protein S down in someone with no inherited problem at all.
- Pregnancy and the weeks after delivery, when free protein S falls substantially as a normal physiological change
- Combined hormonal contraception and menopausal hormone therapy
- Warfarin and other vitamin K antagonists, which lower protein S directly because vitamin K is required to build it
- Direct oral anticoagulants, which interfere with the clot-based activity assay and can produce a falsely low or falsely high reading
- An acute clot, surgery, trauma or any serious infection in the preceding weeks
- Liver disease, which reduces production, and nephrotic syndrome, which loses protein in the urine
- Inflammation of any cause, which raises the carrier protein and lowers the free fraction
- Vitamin K deficiency, covered in our vitamin K blood level guide
- Sample handling, including plasma that has been frozen and thawed before the activity assay was run
For that reason, the practical rule most specialists follow is simple: do not test during pregnancy, during an acute clotting episode, or while taking an anticoagulant, and never diagnose an inherited deficiency from a single abnormal sample. Two clearly low results, drawn on separate occasions in a stable state, plus a supportive family history, is the realistic threshold.
When testing during a clot is unavoidable
Sometimes a doctor orders the whole thrombophilia panel while investigating an acute event, because that is when the patient is in front of them. The results still have value as a baseline, but they cannot confirm a hereditary condition. Other markers behave more usefully in that acute window, particularly the fibrin breakdown product covered in our D-dimer test results guide, and the clotting substrate described in our fibrinogen blood level guide.
What protein S deficiency means for your clot risk
Inherited protein S deficiency is uncommon, affecting roughly one person in several thousand in the general population, and it is one of the recognized causes of unexplained venous clots in younger adults. It raises the lifetime risk of deep vein thrombosis and pulmonary embolism, and it is associated with clots in unusual sites such as the veins draining the brain or the abdomen.
The critical nuance is that raised risk is not the same as certainty. Most people who carry a protein S deficiency never have a clot. Risk becomes real when the inherited tendency meets a trigger: major surgery, long immobility, a cancer diagnosis, estrogen-containing contraception, pregnancy, or a long-haul flight after any of the above. The Centers for Disease Control and Prevention frames venous thromboembolism as largely preventable for exactly this reason, since most of the triggers can be anticipated and managed. If you want the clinical picture of the commonest event, read our deep vein thrombosis overview.
A rare but important scenario concerns newborns who inherit a severe deficiency from both parents. They can develop widespread clotting in the skin within hours of birth, a medical emergency called purpura fulminans. This is exceptional, and it is not what a mildly low adult result implies.
When the protein S test actually changes your care
Testing is worth doing when the answer will alter a decision. That is a higher bar than curiosity, and professional guidance has moved firmly in this direction over the past few years.
The situations where the result genuinely matters include planning whether relatives of a known carrier should avoid estrogen-containing contraception, deciding on preventive treatment around pregnancy or major surgery in a family with documented deficiency, and clarifying whether anticoagulation should continue in someone with a clot in an unusual site. Outside those settings, a positive result frequently changes nothing about the treatment already being given.
Testing has real downsides when done indiscriminately: anxiety about a label that may never cause symptoms, difficulty obtaining insurance in some markets, and the risk of an incorrect diagnosis from a falsely low reading that is never repeated. This is why testing the general population before starting the contraceptive pill is specifically advised against.
When to see a doctor
Regardless of any laboratory value, seek urgent medical attention for swelling, warmth, redness or persistent aching in one calf or thigh, for sudden breathlessness or chest pain that worsens on breathing in, or for coughing up blood. Arrange a non-urgent appointment if you have had an unexplained clot before the age of fifty, repeated clots, a first-degree relative with a known clotting disorder, or repeated pregnancy loss in the second trimester. Bring your full report, including the platelet and clotting numbers explained in our platelet count results guide.
Latest scientific advances
Research published over the last three years has been unusually consistent on one theme: the difficulty is not measuring protein S, it is interpreting the measurement. According to research indexed in PubMed, here is what has emerged and what it means for you.
Guidelines narrowed who should be tested at all
An international expert panel convened by the American Society of Hematology reviewed the evidence on thrombophilia testing and issued a set of recommendations built around one principle: test only when the result would change a decision. The panel advised strongly against screening the general population before starting the combined contraceptive pill, while supporting selective testing in specific situations, such as relatives of someone with a known protein S, protein C or antithrombin deficiency who are weighing preventive treatment or hormone use. What this means for you: if your doctor declines to order a broad clotting panel, that restraint reflects current expert guidance rather than a shortcut, and if testing is offered, it is reasonable to ask which decision the answer will inform.
Laboratory reviews confirmed protein S is the hardest of the group to pin down
A detailed review of thrombophilia laboratory methods concluded that no single assay reliably detects every form of deficiency, and singled out protein S as the most troublesome of the natural anticoagulants. The review noted that activity assays for protein S are widely considered to lack specificity, which is why many laboratories now lead with the free antigen measurement instead. A 2025 expert commentary reached the same conclusion, framing the choice between functional and genetic testing as complementary rather than competing. What this means for you: if your lab reported free protein S rather than activity, that is a deliberate quality decision, and a mismatch between the two numbers is a known pattern rather than a laboratory error.
How the sample was stored can change the answer
A laboratory study compared antithrombin, protein C and protein S activity in fresh plasma against the same samples after freezing. Antithrombin and protein C held steady. Protein S activity fell meaningfully, and some samples that had been normal when fresh were classified as abnormal after freezing. The authors concluded that frozen and thawed plasma risks overdiagnosing protein S deficiency. What this means for you: if a low protein S was found on a sample that travelled to a distant reference laboratory, asking whether a fresh repeat draw is possible is a reasonable question.
A published case shows how the pieces fit together
Clinical chemists described a young woman investigated after an unusual clot in pregnancy. Her first round of testing suggested protein S deficiency. She also carried factor V Leiden, which is known to depress protein S activity readings without affecting antigen measurements. Genetic sequencing found a variant judged to be harmless, and repeat testing eight months later showed normal protein C and a free protein S level at the lower edge of normal. She ultimately did not meet the criteria for deficiency at all. What this means for you: this is exactly the sequence that patience is designed to catch, and it illustrates why a single abnormal result should prompt a repeat rather than a diagnosis. These findings are preliminary in the sense that they come from single cases and laboratory studies, and they are best discussed with the clinician who ordered your test.
Glossary of key terms
| Term | Definition |
|---|---|
| Protein S | A vitamin K-dependent protein made in the liver and vessel lining that helps switch off clot formation once bleeding has stopped. |
| Free protein S | The unbound fraction, roughly 40 percent of the total, that is actually available to do the job. Most laboratories consider it the most dependable screening measurement. |
| C4b-binding protein | An immune system carrier protein that binds protein S and makes it unavailable. Levels rise with inflammation and pregnancy. |
| Activated protein C | The enzyme that protein S assists. Together they inactivate clotting factors Va and VIIIa to keep clot growth in check. |
| Thrombophilia | An inherited or acquired tendency to form blood clots more readily than usual. Protein S deficiency is one of several recognized causes. |
| Factor V Leiden | The commonest inherited clotting variant. It matters here because it can lower a protein S activity reading without any true protein S problem. |
| Venous thromboembolism | The umbrella term covering deep vein thrombosis in a limb and pulmonary embolism in the lungs. |
| PROS1 | The gene that carries the instructions for making protein S. Variants in it can cause inherited deficiency. |
| Purpura fulminans | A rare newborn emergency of widespread skin clotting seen when a severe deficiency is inherited from both parents. |
| Functional assay | A test that measures how well a protein performs its job rather than how much of it is present. |
Frequently asked questions
What is a normal protein S level on a blood test?
Most laboratories report protein S as a percentage of normal pooled plasma, with the lower limit of the reference interval typically falling somewhere between 60 and 70 percent. Ranges differ by assay platform and by whether activity or free antigen was measured, and healthy women generally sit lower than healthy men. Age also matters, since levels are lower in early childhood. The only range that applies to you is the one printed beside your own result, so avoid comparing your number with a figure found elsewhere.
Can protein S deficiency go away?
An inherited deficiency caused by a gene variant is lifelong and does not resolve. An acquired low level often does. If the cause was pregnancy, an infection, a recent clot, liver strain or a medication such as warfarin or an estrogen-containing contraceptive, the level frequently returns to normal once the cause has passed. This is precisely why a repeat test in a stable, unmedicated state is standard practice before anyone is labeled with a deficiency.
Does protein S testing require fasting or a special tube?
Fasting is not usually required. The sample is collected into a tube containing sodium citrate, the same light blue-topped tube used for other clotting studies, and it must be filled to the marked line because an underfilled tube distorts the result. Timing matters more than diet: tell the phlebotomist about any anticoagulant, hormonal contraception or recent illness, and confirm with the ordering clinician whether the draw should be postponed.
Is protein S tested during pregnancy?
Testing during pregnancy is generally discouraged because free protein S falls as a normal part of pregnancy physiology and stays low for weeks afterward, which makes a low result almost impossible to interpret. If thrombophilia assessment is needed, it is usually planned before conception or at least several weeks after delivery and after breastfeeding-related hormone changes settle. Where a family history of a known deficiency exists, preventive care during pregnancy may be planned on the family history alone.
How common is protein S deficiency?
Inherited protein S deficiency is rare, described in roughly one in several thousand people in the general population, though estimates vary widely because of the diagnostic difficulties described above. It is found more often among people investigated after an unexplained clot than in the population at large. Rates also differ between populations, which is one reason laboratories are encouraged to validate reference ranges for the communities they serve.
Should my family be tested if I have protein S deficiency?
This is a conversation for a hematologist rather than an automatic yes. Testing relatives can be worthwhile when the result would change something concrete, such as whether a sister avoids estrogen-containing contraception or whether preventive treatment is planned around surgery or pregnancy. It is less useful when no decision hinges on it, because a positive result can cause lasting worry in someone who may never have a clot.
Sources
- MedlinePlus, National Library of Medicine — Protein C and Protein S Tests — MedlinePlus Medical Test, updated 2025 — medlineplus.gov
- MedlinePlus Genetics, National Library of Medicine — PROS1 gene — MedlinePlus Genetics, updated 2024 — medlineplus.gov
- Centers for Disease Control and Prevention — About Venous Thromboembolism (Blood Clots) — CDC, reviewed 2025 — cdc.gov
- Mayo Clinic — Deep Vein Thrombosis (DVT): Symptoms and Causes — Mayo Clinic, 2022 — mayoclinic.org
- Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, et al. — American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing — Blood Advances, 2023 — doi.org/10.1182/bloodadvances.2023010177
- Moore GW — Thrombophilia Screening: Not So Straightforward — Seminars in Thrombosis and Hemostasis, 2024 — doi.org/10.1055/s-0044-1786807
- Feng H, Song D, Xu Q, et al. — Effect of Frozen Storage Conditions on Antithrombin, Protein C and Protein S Activity Assay Stability — Thrombosis Journal, 2024 — doi.org/10.1186/s12959-024-00640-5
- Hansen RS, Nissen PH, Larsen JB, Bor MV — Diagnosing Protein S Deficiency: Navigating Challenges — Clinical Biochemistry, 2025 — doi.org/10.1016/j.clinbiochem.2025.110950
- Favaloro EJ, Moore GW, Pasalic L — Diagnosing Thrombophilia: The Case for Genetic or Functional Testing? — Expert Review of Molecular Diagnostics, 2025 — doi.org/10.1080/14737159.2025.2588621
Further reading
- Review the panel that frames every clotting workup by reading our complete blood count results guide.
- Explore the other natural brake measured beside protein S in our antithrombin activity lab test guide.
- Assess an inherited cardiovascular risk marker often checked in younger patients with our lipoprotein(a) blood level guide.
- Interpret the size of your platelets and what it signals by reading our mean platelet volume results guide.
- Decode the spread in platelet size reported on the same printout with our platelet distribution width results guide.
Understand your lab results with BloodSense
Get your results interpreted in minutes
A protein S value only makes sense next to the rest of your report: the free antigen alongside the activity figure, the prothrombin time, the platelet count and any anticoagulant you were taking on the day of the draw. BloodSense reads those numbers together and explains in plain language what each one contributes and which questions are worth raising at your next appointment. It helps you understand your results; it does not diagnose you and it does not replace your doctor.
